# Regeneron backs $75M series A for antibody upstart Infinimmune

> **Open Intelligence Dossier** · First detected: 2026-08-11 18:07 UTC · Category: Business

## Executive Summary
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Regeneron backs $75M series A for antibody upstart Infinimmune" is generating significant coverage in the Business category, with 7 articles from 7 distinct sources tracked by PULSE so far.


Outlets currently covering the story include FirstWord Pharma, bizjournals.com, biopharmadive.com and Longevity.Technology. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| FirstWord Pharma | Infinimmune bags $75M for atopic dermatitis antibody duo | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTFBpNjMwdEdMV0lLdTR6b0NQdHpMYlN2TzcxYnpWcjZuTEFKbG5NT2lINnFyZ3dEcUpoY0N4aG1Ld01pTGdKZGF5OWNjWHJMLUFDNVE0?oc=5) |
| bizjournals.com | Alameda biotech Infinimmune scores $75 million as it plans first clinical trials | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxOb2FRMVBtWFBzOVVES0pjcjVmNVYyUmtwVmRsUjFLN0diSFN6R2JSYVJ6Ui15Y01hZEFBSjVpOFRWalpNT0wwSG13VUVfRGM2VGJ0N0o5QzJ5RkRMTVVKRXRHbkg0ZjNvRXJvZ1BTUjB0THk5TnVSNFJSeC1jd1prbnNPTGpscGowbDNTcHh3RV9lNlFsZXNDaGpCNVdselF2WF9PSF90eVZodEROdWVfdw?oc=5) |
| biopharmadive.com | Chasing Dupixent, a biotech aims to make better antibody drugs for eczema | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxOS0V5NWpzLVNCT1lOYXNCb2o2UmxCNzMwTVNkOE85ejBCRUZCR2xLZ204dThod0JFMzZVdnB2V3RUMm1WQzZYR19DQlY4QkI1c052M24tOTJDS3RNdU5pSVRUTGVjUmo5WVM2cDIzN180U1p4dlZKMGdEdlp6VDBHZ2hrTFB5cXRUZ2ZaWHotUTFIbHZqZzB5b1o0R3cxVU1aUkE?oc=5) |
| Longevity.Technology | Re-engineering immune memory for tissue repair | [Source Link](https://news.google.com/rss/articles/CBMiiAFBVV95cUxQdU1fNlUwNjRXYlJpbXNtdEVEWjFxOXNCWm15TXJQMnJDMFZYVWxXTVEyQ3l6cXFKcElZdkYtSDdGMkJVNmM2MThtRnNSdmU1SW9BMF9qOWtSTEM5TjVlR3B2d0NCRTBpdEdyR2RrRWY4aEM1V3djS253QVRHcHY1UnIzbGdOMW9l?oc=5) |
| Business Wire | Infinimmune Raises $75 Million Series A Financing to Advance Pipeline of Human-Derived Antibodies for Atopic Dermatitis and Inflammatory Disease | [Source Link](https://news.google.com/rss/articles/CBMiqwJBVV95cUxQTXNmaVRIVHZpVTlmOHYzdUxWZmFZX1UzWmxIcXUwUlNwbW1NSEhWclJ2ek5FanZ0VUs3NDdLaU5hSWZfRjBrV3pfbXBLdFZRZFlNcVd4Q1g1d3ozeXdHZmRtOW45aVpacktvWmhJaW1kQ1BmZmxFYzFnUlFfWXlrdFlpQnA5emRNdE9OZ205YUpnQl9RWGNZOEdCS2FhS3dLNU9CUVN5Z19yb3BCSjFQVWZLc09ScFduODIyMWNramxkS3JheEpCbnVHdXdkcThwZ2ZtR3JfOWk3SVl5YU9OeGl1c3ZjdDhIYTZBUmlYaXBhcGtDZmhmanhmVTFZMFFvS3lKY2lLRExaX3J2OWppRExRNUFXU0dVdmlUdmxEM1YxYzJPaE16eTRiVQ?oc=5) |
| Endpoints News | Lilly paid $2B upfront for vaccine biotechs; Infinimmune raises $75M | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxPeVFFZmFsajNpR3h2VnZVcUctZ3hMZUNBUkVhR1JlaDFoVTlYR0FUUGVEWVBJMWFXSi1WM3cwZms3OGhTX1RzNFhjZnBqLUVGUV9zZ3BDTFo1NDNPYVQyazFTbVptLUt4eFVwV0VBYjhfQnVJcVN1Wk1TZU1RREEzQ01iQUk2Q1VZaEo0Ykpid0xZN28?oc=5) |
| Fierce Biotech | Regeneron backs $75M series A for antibody upstart Infinimmune | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxPTXB0Q2NuRkVraGNzcEpOb2VuY0ZNUlNocWgxbDlLUXFyQTM5QU53T2FTZWNKVzFVMXRvN1c1QnltOUpiOHF2dTVLVlZTOXc0Ymhac3pMcXJPRUdOMW5DdWJtWHk1QzVWZXFQQWc3R1lnZzlrSWVrZnhHS0pNa2hzNkdCSjBLT2QzZ3JWWDF0Z29KRzhiQUd2Qg?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-11/regeneron-backs-75m-series-a-for-antibody-upstart-infinimmune*